R&D Pipeline
Proprietary Diagnostics
Videssa® Breast: Cancer Blood Test
LymPro™: Alzheimer's Blood Test
TolloTest™: Coronavirus 3CL Protease Test
TBIA: AI Cancer Platform
Antiviral Drug Development
Tollovir™: 3CL Protease Inhibitor
Products & Services
Lab Solutions
Provista Diagnostics: CLIA/CAP Lab
COVID Testing: Lab Supplies & Automated Solutions
Dietary Supplement
Tollovid™: 3CL Protease Inhibitor
Insights
Publications
News & Media
Downloads
How It Works: 3CL Protease Inhibitors
Case Study: Lab Automation
Investors
About
Management Team
Board of Directors
Advisors
Career Opportunities
Add a button link here
Contact Us
Financial Results
Investors
Investors
Overview
News & Events
Press Releases
IR Calendar
Email Alerts
Company Info
Management Team
Presentations
Contacts
FAQ
Financial Info
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Board of Directors
Governance Documents
2021
Q3 2021
Quarter Ended Sep 30, 2021
Earnings Release
PDF
HTML
10-Q
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
Q2 2021
Quarter Ended Jun 30, 2021
Earnings Release
PDF
HTML
10-Q
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
Q1 2021
Quarter Ended Mar 31, 2021
10-Q
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
2020
FY 2020
Fiscal Year Ended Dec 31, 2020
10-K
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
2019
FY 2019
Fiscal Year Ended Dec 31, 2019
20-F
Filing
PDF
HTML
20-F/A
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
2018
FY 2018
Fiscal Year Ended Dec 31, 2018
20-F
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
2017
FY 2017
Fiscal Year Ended Dec 31, 2017
20-F
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
2016
FY 2016
Fiscal Year Ended Dec 31, 2016
20-F
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
Email Alerts
Company Profile
Contacts
RSS News Feed
